Abiomed, Inc. Reports Unaudited Revenue Results for the Third Quarter of Fiscal 2018; Upgrades Earnings Guidance for the Fiscal Year 2018
Preliminary fiscal 2018 guidance has been upgraded to approximately $582 million, an increase of approximately 31% from the prior year. This compares to prior fiscal 2018 guidance of $565 million to $575 million.